Clinical Trials Directory

Trials / Completed

CompletedNCT02250287

New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease

Pilot and Feasibility Study: Evaluation of New Quantitative Magnetic Resonance Imaging Parameters in Assessing the Kidneys of Autosomal Dominant Polycystic Kidney Disease

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to establish normal Magnetic Resonance quantitative values (tissues stiffness, Apparent Diffusion Coefficient values and Blood Oxygen Level Determination values for both renal cortex and medullary tissues and total renal blood flow) for young Autosomal Dominant Polycystic Kidney Disease patients with normal renal function, and normal young adult controls without Autosomal Dominant Polycystic Kidney Disease and normal renal function. Hypothesis: Newer Magnetic Resonance quantitative imaging parameters (tissue stiffness, Apparent Diffusion Coefficient, Blood Oxygen Level Determination levels, Magnetization Transfer and renal blood flow) will have different values in young adult ADPKD patients as compared to normal volunteers.

Conditions

Timeline

Start date
2014-12-01
Primary completion
2016-03-01
Completion
2016-03-01
First posted
2014-09-26
Last updated
2016-06-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02250287. Inclusion in this directory is not an endorsement.